Welcome to our dedicated page for Prospect Capital SEC filings (Ticker: PSEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Prospect Capital’s disclosures can feel like a maze—hundreds of pages on fair-value marks, collateral tests, and CLO cash-flow waterfalls. If you have ever asked, “Why is net investment income buried so deep in the Prospect Capital annual report 10-K?” this page is built for you. Stock Titan delivers Prospect Capital SEC filings explained simply, transforming dense BDC language into clear insights you can act on.
As each document hits EDGAR, our platform posts it within seconds and layers on AI-powered summaries that highlight what matters: portfolio yield shifts in a Prospect Capital quarterly earnings report 10-Q filing, leverage covenant updates in an 8-K, or dividend coverage trends pulled from management discussion. Want instant alerts? We stream Prospect Capital Form 4 insider transactions real-time so you never miss a director’s buy or sale. The same engine demystifies the Prospect Capital proxy statement executive compensation, breaking out base fees, incentive fees, and hurdle rates without the legalese. Key filings you can explore include:
- Prospect Capital insider trading Form 4 transactions—track executive moves as they happen
- Prospect Capital 8-K material events explained—new CLO launches or portfolio impairments in plain English
- understanding Prospect Capital SEC documents with AI—quick answers to leverage tests, asset coverage, and dividend safety
- Prospect Capital earnings report filing analysis—AI context around NII per share and NAV changes
- Prospect Capital executive stock transactions Form 4—identify buying patterns before dividend announcements
Whether you’re modeling cash flows or just need the Prospect Capital annual report 10-K simplified, Stock Titan condenses every note, chart, and footnote into concise takeaways. Save hours, uncover risks earlier, and make decisions with confidence—without scrolling through endless PDFs.
Prospect Capital Corporation entered a material financing, issuing approximately $167 million aggregate principal amount of 5.5% Series A Notes due 2030. The notes are senior unsecured, pay interest quarterly starting March 31, 2026, and are expected to list on the Tel Aviv Stock Exchange on November 2, 2025. Net proceeds are estimated at $160 million, which the company expects to use primarily to refinance existing debt, including borrowings under its revolving credit facility, with any remainder for liquidity and investments aligned with its objective.
The notes may be redeemed, after 60 days from TASE listing, at the greater of par plus accrued interest, the 30‑day average closing price before board approval, or the discounted value of remaining payments, as defined in the deed of trust. Covenants include minimum total equity, a maximum net debt‑to‑total assets ratio, a minimum equity‑to‑total assets ratio, and a negative pledge. The notes, governed by Israeli law and issued under Regulation S, were sold to non‑U.S. persons offshore. The company also entered foreign exchange forwards covering expected interest and principal on the shekel‑denominated notes. Common stock is also expected to list on the TASE on November 2, 2025.
Prospect Capital Corporation filed Post-Effective Amendment No. 118 to its Form N-2 registration statement (File No. 333-269714). The filing was made under Rule 462(d) solely to add and file exhibits and, per the company, does not modify any other part of the registration statement.
The amendment becomes effective immediately upon filing with the SEC. Prospect Capital is registered as a closed-end fund regulated as a business development company. The base registration contemplates securities that may be offered from time to time after effectiveness; this amendment is an administrative update limited to exhibits.
Prospect Capital Corporation announced it priced an institutional offering of approximately $167 million in aggregate principal amount of 5.5% Series A Notes due 2030. The Notes pay interest quarterly on March 31, June 30, September 30 and December 31, commencing March 31, 2026, and mature on December 31, 2030. They are general senior unsecured obligations, ranking equally with existing and future senior unsecured debt, and are rated ilAA- by S&P Global Ratings Maalot Ltd.
The offering is expected to close on October 30, 2025, with the Notes and the Company’s common stock expected to list and commence trading on the Tel Aviv Stock Exchange on November 2, 2025. The Company may redeem the Notes, in whole or in part, at any time after 60 days from the TASE listing at the greater of par plus accrued interest, the 30-day average closing price prior to board approval, or the discounted value of remaining payments. Net proceeds are expected to be used primarily to refinance existing indebtedness, including borrowings under the revolving credit facility, with any remainder for liquidity and investments consistent with its objectives.
Prospect Capital Corporation filed a preliminary pricing supplement for new Prospect Capital InterNotes, offering fixed-rate senior unsecured notes in three tranches: 6.250% Notes due 2028, 6.500% Notes due 2030, and 6.750% Notes due 2032, each sold at 100.000% of principal. The notes pay interest semi-annually on May 15 and November 15, starting May 15, 2026, with record dates on May 1 and November 1. Each series is callable at 100.000% beginning May 15, 2026, and includes a Survivor’s Option.
The trade date is November 3, 2025 with settlement on November 6, 2025. Minimum denominations are $1,000 and integral multiples thereof, DTC book-entry only. Notes will be sold through InspereX as Purchasing Agent, with agent concessions of 1.125% (2028), 1.700% (2030), and 1.950% (2032). In recent activity, the company repurchased $20.3 million aggregate principal of its 3.437% 2028 Notes at prices of 88.95%–89.95%, plus accrued interest.
Prospect Capital Corporation priced three new Prospect Capital InterNotes under its shelf, issuing fixed‑rate senior unsecured notes due 2028, 2030 and 2032. The tranches are: 6.250% Notes due 2028 with $415,000 principal, 6.500% Notes due 2030 with $74,000, and 6.750% Notes due 2032 with $52,000, each sold at 100.000% of principal.
Net proceeds are $410,331.25 (2028), $72,742.00 (2030) and $50,986.00 (2032) after selling concessions. Interest is paid semi‑annually on April 15 and October 15, beginning April 15, 2026. Each series includes a Survivor’s Option and is callable at 100.000% on April 15, 2026 and every business day thereafter, plus accrued interest.
The notes settle on October 30, 2025 in DTC book‑entry form and are issued under the existing 2012 Indenture, as further supplemented. Recent activity includes the repurchase of $20.3 million aggregate principal of the 3.437% 2028 Notes at 88.95%–89.95%, plus accrued interest.
Prospect Capital Corporation filed Post-Effective Amendment No. 117 to its Form N-2 registration statement (Reg. No. 333-269714). The filing, made under Rule 462(d), is solely to add exhibits and becomes effective immediately upon filing. It does not modify any other part of the registration statement.
The registration statement contemplates offerings “from time to time after the effective date.” This amendment consists of a facing page, an explanatory note, and Part C listing the exhibits, which are incorporated by reference.
Prospect Capital Corporation launched a primary offering of Prospect Capital InterNotes under its shelf, with three fixed-rate tranches: 6.250% Notes due 2028, 6.500% Notes due 2030, and 6.750% Notes due 2032. Each note pays interest semi-annually on April 15 and October 15, starting April 15, 2026, and is callable at 100% beginning April 15, 2026 and on any business day thereafter.
The notes will be sold at 100.000% of principal, with selling concessions of 1.125% (2028), 1.700% (2030), and 1.950% (2032). Minimum denomination is $1,000, DTC book-entry only. A Survivor’s Option applies as stated, allowing repayment at 100% of principal plus accrued interest, subject to annual aggregate and per-decedent limits.
Key dates include a trade date of October 27, 2025 and settlement on October 30, 2025. Recent activity noted a repurchase of $20.3 million aggregate principal of the 3.437% 2028 notes at prices between 88.95% and 89.95%, plus accrued interest.
Prospect Capital Corporation priced three Prospect Capital InterNotes under its 424(b)(2) program: 6.250% Notes due 2028 ($189,000 principal), 6.500% Notes due 2030 ($135,000), and 6.750% Notes due 2032 ($55,000). Each series priced at 100% of principal with semi-annual interest and first coupons on April 15, 2026.
The 2028 Notes carry a 1.125% gross concession with net proceeds of $186,873.75; the 2030 Notes carry a 1.700% gross concession with net proceeds of $132,705.00; the 2032 Notes carry a 1.950% gross concession with net proceeds of $53,927.50. All are unsecured senior obligations with a Survivor’s Option and are callable at 100% on April 15, 2026 and thereafter, plus accrued interest.
Trade date was October 20, 2025, with settlement on October 23, 2025, $1,000 minimum denomination, DTC book-entry. Recent activity disclosed a repurchase of $20.3 million aggregate principal of 3.437% 2028 Notes at 88.95%–89.95%, plus accrued interest.
Prospect Capital Corporation filed Post-Effective Amendment No. 116 to its Form N-2 registration statement (Registration No. 333-269714). The filing was made under Rule 462(d) solely to add exhibits and became effective immediately upon filing.
The amendment consists of a facing page, an explanatory note, and Part C listing exhibits, and it does not modify any other part of the registration statement. The registration statement continues to permit offerings from time to time after the effective date.
Prospect Capital Corporation (PSEC) filed Post-Effective Amendment No. 115 which records corporate housekeeping details including entities it controls as of
FAQ
What is the current stock price of Prospect Capital (PSEC)?
What is the market cap of Prospect Capital (PSEC)?
